Jumps 23% to $45M in 2022 — NameSilo revenue

Revenue was up, but bookings were flat.

Domain name registrar NameSilo (CSE: URL) (PINKSHEETS: URLOF) noted 2022 earnings today.
The firm grew revenue by 23.5% to $45.0 million and noted a gross profit of $8.0 million.
Total bookings only nudged up 2.9% to $46 million. Since registration revenue is recognized over the term of the registration, the firm will have to find fresh growth during this year to boost its revenue, given the mostly flat bookings growth last year.
NameSilo’s net income numbers aren’t very relevant to the domain industry since the firm holds investments in 13 other firms that it sometimes marks to market. The largest of these is ImmunoPrecise Antibodies Ltd, right now valued at regarding $4 million.
In management discussion of the results, the firm revealed that 95.0% of its revenue is from domain registrations. 3.6% is from domain marketplace services, and 1.4% is from hosting and email.



